• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    OEMs Seek Molders Offering Timely Techniques

    Robotic Surgery: Cutting Through to the Latest

    Packaging, Sterilization Considerations Go Part and Parcel with Product Development

    Cybersecurity Challenges Leave Medical Device Makers Insecure

    OEMs Are Demanding Designs that Challenge Suppliers
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    MPO's Most-Read Stories This Week—July 2

    OmniGuide Awarded FDA Clearance for RevoLix Hybrid Thulium Laser

    Pancryos Forges License Agreement for Microencapsulation Device

    FDA Awards IDE Approval to SELUTION SLR Drug-Eluting Balloon

    Matt Rainville Joins Bigfoot Biomedical as Chief Commercial Officer
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    OEMs Seek Molders Offering Timely Techniques

    Robotic Surgery: Cutting Through to the Latest

    Packaging, Sterilization Considerations Go Part and Parcel with Product Development

    Cybersecurity Challenges Leave Medical Device Makers Insecure

    OEMs Are Demanding Designs that Challenge Suppliers
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Theranos Fraud Trial, Part II: The Blame Game Continues

    An Update on Surgical Robotics

    Letting the Light In: How Failure Analysis is the Cornerstone of Success

    Three Talent Strategies to Attract High-Demand Skills

    The Advantages of Bioburden Screening for Sterilization Validation
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Xact Wire EDM Corp.

    Fusion Biotec Inc.

    Cirtec Medical

    Trademark Plastics Inc.

    BMP Medical
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    ‘Right to Repair’: Separating Fact from Fiction

    Taking a Holistic Approach to Decentralized Clinical Trials (DCTs)

    Investment in Health Startups Drops

    The Power of Leveraging Customer Relationships

    Cost Effective & Efficient Wire EDM Techniques
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Xact Wire EDM Corp.

    Fusion Biotec Inc.

    Cirtec Medical

    Trademark Plastics Inc.

    BMP Medical
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    4 Ways to Align Product Development with Investor Milestones

    Aligning all technical activities around the investor gates typically means, the whole company must be aligned around lean startup milestones.

    4 Ways to Align Product Development with Investor Milestones
    Image courtesy of StarFish Medical.
    Scott Phillips, Founder and CEO, StarFish Medical06.01.22
    In our business, entrepreneurial founders often ask what they can do to create the most value for themselves. After 23 years and participating in hundreds of medtech stories, I believe creating founder value has a lot to do with focusing on value an investor would recognize.

    The lean medtech startup journey is about investment efficiency and risk mitigation. It envisions the startup as a series of experiments, prioritized by risks. Unsurprisingly, the typical technical phase-gates in a development process correspond quite well with typical investor milestones.

    The pre-seed round typically happens in the conceptual development phase, culminating in a seed round once the conceptual development gate is passed. The A round often happens about when an alpha prototype is ready and tested. Sometimes there’s a second A round to fund clinical testing and detailed product design. The B round often happens when the Beta/commercial prototype is tested, clinical testing is done, initial market regulatory approval has been submitted, and launch preparations are underway. These technical milestones typically correspond to major reductions in investor/business risk.

    We have found realized exit value is often heavily influenced by product/consumable margin and scalability, but early market companies don’t have the scale to achieve margins yet. (Navigating that judo trick is a topic for a future article.)

    Aligning all technical activities around the investor gates typically means, in practice, the whole company must be aligned around lean startup milestones and risk mitigations. Easy to say, but we often see misalignments inside companies on how to prioritize different risks. How should you compare relative value of improved firmware vs. usability insight vs. a regulatory approach vs. an IP strategy vs. technical proof-of-concept vs. better user needs assessment? How good is good enough in each of those areas? In practice this dance is infinitely complex. Unless the approach is very deliberate a lot of effort can be wasted resulting in unnecessary founder dilution, which can become critical later. 

    1. Never Gild the Lily 
    Each round of prototyping and proof of concept should never be more refined than necessary. The prototype is for a specific limited purpose—perhaps to prove a technical challenge can be overcome, or some influential users will endorse the concept. Maybe it’s to develop a core concept so IP can be filed, or so early clinical or animal data can be gathered. What is the fastest and cheapest way the desired outcome can be reached? Investors have a lot of big picture concerns on their minds.

    2. Teach People What Matters 
    The approach of minimalism by investor milestone is often counterintuitive to engineers. They believe they’re trying to optimize overall cost and timeline and often want to make each prototype as good as it can be to save money later. However, the startup company is spending dollars, not shares. If the company is successful in reducing risks and proving value, shares will become more valuable later. Spending future shares to address issues with present prototypes is more effective, even if it costs extra later. We’ve found once engineers understand the game, they are more than capable of finding the right compromises. Business leaders often forget those on the design front lines make judgments every day on how much to refine design aspects. The better their knowledge of the context, the better their decisions will be. 

    A client had once presold their technology to another company on the condition they could achieve certain clinical demonstrations. Anything beyond that demonstration was money they’d never see again and would get no return on. Once the engineers understood that goal, they could focus solely on requirements for a speedy and cost-effective clinical demonstration. 

    Another client needed to demonstrate market traction as quickly as possible and placed lower weight on margin. Early market validation would allow them to resolve their biggest business risk. We could first focus on speed, then margin and manufacturability improvements in a second iteration. The client raised the capital needed for launch and rollout—without aligning the engineers to these business goals, they might have chosen different priorities in their technical work. 

    3. Technical Milestones Are Really in Service of Business Questions 
    Another typical corollary is that technical milestones are really in service of business questions. The technical team easily forgets this. A working prototype is only useful in that it produces evidence: usability data, animal data, or clinical results.

    One client wanted 300 clinical prototypes in the conceptual development stage. It was unusual, but the patient risk was “non-significant” and the business question was an important one. They wanted to prove the disease state they were looking for could be detected in the field. Even at the cost of a more formal trial later, they were willing to pay to get information early, likely a good business decision. 

    The biggest and trickiest business question is “does anybody care?” It’s also a difficult question to tackle in early going. That’s where the lean medtech startup differs from the more agile internet SaaS startups. In this industry, we don’t get the luxury of selling things prematurely; there are regulatory barriers in place for good reasons. We must find other ways to access market proxies. Sometimes we make usability prototypes simply to let target users test the product and get a feel for whether they would use it in practice. The result can be a strong investor signal.

    4. Don’t Lock in Specs Too Early 
    Another thing people often miss is how to achieve the best solution they’re entitled to. The key point of the lean medtech startup, in our experience, is incrementally working out the best business value proposition that maps the clinical indication and technical approach together. Sometimes, even those evolve—preserving some ambiguity until later allows the right amount of flexibility, and that flexibility is potential. The right creative team can find a better solution than had been originally imagined. 

    For example, a few years ago we had a surgical project involving a laser, and we received a fairly detailed spec for a design for manufacturability exercise for a handpiece. We got about halfway through that project and the engineer suddenly realized, “Oh my gosh, what this company actually wants here is not a design for manufacturability, what they want is a favorable exit.” Their business trajectory and their narrative was they wanted to sell the company and wanted to sell this product off for many millions of dollars and have a big impact.

    He could see the value of the transaction was going to be driven by the disposable margin. It wasn’t about the design for manufacturability per se—because the buyer would redesign it later—and the proof-of-concept was already established for the technology. The key challenge was about demonstrating high margin potential for the key consumable element, which meant getting an expensive exotic optical fiber as short as possible. That approach really transformed the project and a few months later they did the exit for many more millions of dollars than they had hoped for. A substantial amount of that value was driven by the engineer’s insight, which had nothing to do with the spec. 

    While matching activities to investor milestones in a medtech startup seems straightforward, in practice it is anything but easy. Having everybody aligned on the goal is a good start but isn’t sufficient. Different people will naturally have different interpretations of what those goals mean. I hope the principles I have laid out here are useful guides for how to align your technical team’s activities in support of your lean medtech startup journey. 


    Scott Phillips has a degree in engineering physics from the University of British Columbia. Prior to starting StarFish, he worked in lithium battery development and manufacturing, UV spectroscopy instrumentation and hi-fi audio speakers. Under his leadership StarFish has grown into a diverse professional organization with clients around the world and 100 percent focus on medical devices. Scott is a chair of the LifeSciences British Columbia board, member of the 2022 VIATEC Board of Directors, Fellow of The Canadian Academy of Engineering, winner of the EY Entrepreneur Of The Year 2017 Pacific Awards Technology category, 2017 recipient of the VIATEC Technology Champion award, and volunteers with Junior Achievement, Entrepreneurs Organization, and University of British Columbia.
    Related Searches
    • R&D & Design
    Related Knowledge Center
    • R&D & Design
    Loading, Please Wait..

    Trending
    • How To Overcome The Top 6 Medical Device Manufacturing Challenges
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • AI-Enabled SKOUT Device Improves Colorectal Cancer Screening
    • 5 Ways Plastics Revolutionized The Healthcare Industry
    • 7 Steps To Create Your Own Medical Device Marketing Plan
    Breaking News
    • MPO's Most-Read Stories This Week—July 2
    • OmniGuide Awarded FDA Clearance for RevoLix Hybrid Thulium Laser
    • Pancryos Forges License Agreement for Microencapsulation Device
    • FDA Awards IDE Approval to SELUTION SLR Drug-Eluting Balloon
    • Matt Rainville Joins Bigfoot Biomedical as Chief Commercial Officer
    View Breaking News >
    CURRENT ISSUE

    June 2022

    • OEMs Seek Molders Offering Timely Techniques
    • Robotic Surgery: Cutting Through to the Latest
    • Packaging, Sterilization Considerations Go Part and Parcel with Product Development
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Pharmavite Expands in Ohio with $200 Million Investment
    Nestlé Health Science Expands in New Zealand with Deal to Buy The Better Health Company
    Younger Consumers Drive Growing Demand for Ingestible Beauty and Skin Care Products
    Coatings World

    Latest Breaking News From Coatings World

    Azelis Acquires Chemical Partners, Strengthens Leadership in Africa and Middle East
    Emmanuelle Bromet Named Arkema Sustainable Development VP
    ROSS Planetary Dual Dispersers Have Unique Processing Flexibility
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MPO's Most-Read Stories This Week—July 2
    OmniGuide Awarded FDA Clearance for RevoLix Hybrid Thulium Laser
    Pancryos Forges License Agreement for Microencapsulation Device
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Bayer Opens New Research and Innovation Center at Kendall Square
    Lonza Names Maria Soler Nunez as Head, Group Operations
    Eurofins DiscoverX Opens Shanghai Office
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Dexlevo Introduces Beauty Treatment technique, ‘GOURI’
    Revision Skincare Exec Wins Ernst & Young Entrepreneur of the Year
    Latest Updates About Cosmoprof North America
    Happi

    Latest Breaking News From Happi

    SCOTUS EPA Ruling Won’t Impact General Regulatory Authority
    Toning Collection For Zero-Brass Blondes is New at Colorproof
    Esthetician Studio Beauty Concepts Files Trademark Infringement Lawsuit Against Kim Kardashian and Coty, Inc.
    Ink World

    Latest Breaking News From Ink World

    Weekly Recap: Flint OPS, Xerox and MNYPIA Top This Week’s News
    Azelis Acquires Chemical Partners, Adds to Leadership in Africa and Middle East
    International Paper Publishes 2021 Sustainability Report
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    UPM Raflatac boosts operations in US, All4Labels returns to HP and more
    Fedrigoni Self-Adhesives to exhibit at Labelexpo Americas for first time
    CELAB Europe wins Paper Recycling award
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Weekly Recap: Lifetime Technical Achievement Award Presented to Richard Knowlson, Alkegen Completes Luyang Acquisition & More
    Glatfelter, Blue Ocean Closures Partner with Absolut
    What You’re Reading on Nonwovens-Industry.com
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ODT's Most-Read Stories This Week—July 2
    NuVasive Inc. Opens Singapore Experience Center
    Pedicle Screw Systems Market to Top $3B in 2027
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Weekly Recap: eMagin, Identiv, and Japan Display Top This Week’s Stories
    Epishine is Building a New Solar Cell Factory in Linköping, Sweden
    Toppan Establishes CVC Fund and Investment Management Company in the US

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login